Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Author: Benzinga Insights | May 26, 2022 07:08am

 

Gainers

  • TC BioPharm (Holdings) (NASDAQ:TCBP) stock rose 71.6% to $1.09 during Thursday's pre-market session. The market value of their outstanding shares is at $30.5 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock rose 15.49% to $0.82. The company's market cap stands at $2.8 million. As per the news, the Q1 earnings report came out 3 days ago.
  • Monopar Therapeutics (NASDAQ:MNPR) shares moved upwards by 14.81% to $2.48. The company's market cap stands at $31.2 million.
  • Liquidia (NASDAQ:LQDA) shares moved upwards by 9.04% to $3.98. The market value of their outstanding shares is at $256.0 million.
  • Evelo Biosciences (NASDAQ:EVLO) shares increased by 8.88% to $1.96. The company's market cap stands at $105.1 million.
  • Concert Pharma (NASDAQ:CNCE) stock increased by 8.11% to $5.06. The company's market cap stands at $183.8 million.

Losers

  • NRX Pharmaceuticals (NASDAQ:NRXP) shares decreased by 39.9% to $0.83 during Thursday's pre-market session. The market value of their outstanding shares is at $55.3 million.
  • Avadel Pharmaceuticals (NASDAQ:AVDL) shares decreased by 23.08% to $2.6. The market value of their outstanding shares is at $153.4 million.
  • Genocea Biosciences (NASDAQ:GNCA) stock decreased by 8.7% to $0.08. The company's market cap stands at $4.9 million.
  • Motus GI Hldgs (NASDAQ:MOTS) shares declined by 8.34% to $0.28. The company's market cap stands at $15.1 million.
  • Verrica Pharmaceuticals (NASDAQ:VRCA) stock declined by 7.97% to $1.85. The company's market cap stands at $50.9 million.
  • Bluejay Diagnostics (NASDAQ:BJDX) shares decreased by 7.41% to $1.0. The company's market cap stands at $20.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVDL BJDX CNCE EVLO GNCA LQDA MNPR MOTS NRXP RSLS TCBP VRCA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist